Free Trial

Conduit Pharmaceuticals (CDT) Competitors

Conduit Pharmaceuticals logo
$2.80 +0.01 (+0.36%)
Closing price 04:00 PM Eastern
Extended Trading
$2.73 -0.07 (-2.50%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CDT vs. GNPX, PMCB, AIM, SLXN, TCRT, OMGA, INAB, HCWB, SBFM, and CDIO

Should you be buying Conduit Pharmaceuticals stock or one of its competitors? The main competitors of Conduit Pharmaceuticals include GENPREX (GNPX), Nuvilex (PMCB), AIM ImmunoTech (AIM), Silexion Therapeutics (SLXN), Alaunos Therapeutics (TCRT), Omega Therapeutics (OMGA), IN8bio (INAB), HCW Biologics (HCWB), Sunshine Biopharma (SBFM), and Cardio Diagnostics (CDIO). These companies are all part of the "pharmaceutical products" industry.

Conduit Pharmaceuticals vs. Its Competitors

Conduit Pharmaceuticals (NASDAQ:CDT) and GENPREX (NASDAQ:GNPX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/A-$17.80M-$534.48-0.01
GENPREXN/AN/A-$21.11MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Conduit Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
GENPREX
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

3.3% of Conduit Pharmaceuticals shares are held by institutional investors. Comparatively, 14.1% of GENPREX shares are held by institutional investors. 4.1% of Conduit Pharmaceuticals shares are held by insiders. Comparatively, 8.5% of GENPREX shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Conduit Pharmaceuticals and Conduit Pharmaceuticals both had 1 articles in the media. GENPREX's average media sentiment score of 1.00 beat Conduit Pharmaceuticals' score of 0.94 indicating that GENPREX is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Conduit Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GENPREX
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Conduit Pharmaceuticals has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500. Comparatively, GENPREX has a beta of -0.5, meaning that its share price is 150% less volatile than the S&P 500.

Conduit Pharmaceuticals' return on equity of 0.00% beat GENPREX's return on equity.

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A -435.57%
GENPREX N/A -664.65%-370.18%

Summary

Conduit Pharmaceuticals beats GENPREX on 5 of the 9 factors compared between the two stocks.

Get Conduit Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDT vs. The Competition

MetricConduit PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.23M$2.42B$5.54B$8.87B
Dividend YieldN/A1.77%5.39%4.10%
P/E Ratio-0.018.7226.1719.90
Price / SalesN/A663.86414.67113.66
Price / CashN/A151.5836.1356.90
Price / Book-0.044.548.055.38
Net Income-$17.80M$31.16M$3.15B$248.50M
7 Day Performance14.29%0.15%1.85%2.97%
1 Month Performance-28.93%8.81%4.81%6.02%
1 Year Performance-99.79%2.55%34.86%20.39%

Conduit Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDT
Conduit Pharmaceuticals
N/A$2.80
+0.4%
N/A-99.8%$2.23MN/A-0.013
GNPX
GENPREX
1.6895 of 5 stars
$0.23
-13.2%
N/A-85.9%$7.34MN/A0.0020Gap Up
High Trading Volume
PMCB
Nuvilex
1.7598 of 5 stars
$1.06
flat
N/A-41.8%$7.28MN/A1.434Gap Down
AIM
AIM ImmunoTech
1.9465 of 5 stars
$9.50
+3.1%
$275.00
+2,794.7%
-75.6%$7.26M$146K-20.2120News Coverage
SLXN
Silexion Therapeutics
N/A$0.82
+0.1%
$5.00
+512.7%
N/A$7.08MN/A0.00N/A
TCRT
Alaunos Therapeutics
0.7789 of 5 stars
$4.48
+4.4%
N/A-28.0%$7.03M$10K0.0040News Coverage
OMGA
Omega Therapeutics
2.5844 of 5 stars
$0.13
-21.8%
$8.50
+6,700.0%
-94.4%$6.92M$8.10M-0.09120Gap Up
INAB
IN8bio
3.0196 of 5 stars
$2.23
+2.3%
$180.00
+7,971.7%
-91.5%$6.59MN/A-0.1620High Trading Volume
HCWB
HCW Biologics
3.3414 of 5 stars
$4.67
+2.2%
$35.00
+649.5%
-85.6%$6.58M$2.57M-0.2040News Coverage
Gap Down
SBFM
Sunshine Biopharma
3.2098 of 5 stars
$1.43
-0.7%
$15.00
+949.0%
+259.9%$6.56M$34.87M-0.013News Coverage
CDIO
Cardio Diagnostics
3.2829 of 5 stars
$3.70
-0.3%
$60.00
+1,521.6%
-77.7%$6.45M$40K0.001

Related Companies and Tools


This page (NASDAQ:CDT) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners